相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FOXM1: From cancer initiation to progression and treatment
Chuay-Yeng Koo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
Yun-Yong Park et al.
CARCINOGENESIS (2012)
Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
Ka-Kei Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The p38 MAPK-MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment
Natalia de Olano et al.
MOLECULAR CANCER RESEARCH (2012)
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
C. T. Karadedou et al.
ONCOGENE (2012)
ERβ1 Represses FOXM1 Expression through Targeting ERα to Control Cell Proliferation in Breast Cancer
Yoshiya Horimoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
Shahab Uddin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors
Zebin Wang et al.
CANCER RESEARCH (2011)
FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
Miranda S.C. Wilson et al.
CURRENT DRUG TARGETS (2011)
被撤回的出版物: Over-Expression of FoxM1 Leads to Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells (Retracted article. See vol. 117, pg. 1963, 2016)
Bin Bao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
Julie Millour et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Induction of Human Epithelial Stem/Progenitor Expansion by FOXM1
Emilios Gemenetzidis et al.
CANCER RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Jimmy M. -M. Kwok et al.
MOLECULAR CANCER RESEARCH (2010)
FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance
J. Millour et al.
ONCOGENE (2010)
Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer
Jie Chen et al.
PLOS ONE (2010)
A role for menstruation in preconditioning the uterus for successful pregnancy
Jan J. Brosens et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Ursula B. McGovern et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
Serena T. Wong et al.
PHARMACOTHERAPY (2009)
Resist or die FOXO transcription factors determine the cellular response to chemotherapy
Ana R. Gomes et al.
CELL CYCLE (2008)
The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression
Rosaline C. -Y. Hui et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells
Silvia Fernandez de Mattos et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
Rosaline C-Y. Hui et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Many forks in the path: cycling with FoxO
K. K. Ho et al.
ONCOGENE (2008)
Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Antonella Brunello et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2008)
The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells
Janna Krol et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes
Yongjun Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
FOXO3a induces differentiation of Bcr-Abl- transformed cells through transcriptional down-regulation of Id1
Kim U. Birkenkamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
FOXO transcription factors: key regulators of cell fate
E. W-F. Lam et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
The forkhead box M1 protein regulates the transcription of the estrogen receptor α in breast cancer cells
Patricia A. Madureira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-Terminal kinase and Akt
A Sunters et al.
CANCER RESEARCH (2006)
Adjuvant chemotherapy for early breast cancer:: Optimal use of epirubicin
S Glück
ONCOLOGIST (2005)
Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells
A Essafi et al.
ONCOGENE (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism
SF de Mattos et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
